Rimabotulinumtoxinb + Botulinum Toxin Type A Interaction
Majorinteraction on record
Description
Concurrent or overlapping administration (within 4 months) may exacerbate excessive neuromuscular weakness and paralysis.
Mechanism
Potentiation of neuromuscular paralysis
Source: NLP:rimabotulinumtoxinb